Added to YB: 2025-12-30
Pitch date: 2025-12-29
DVYSR.ST [bullish]
Devyser Diagnostics AB (publ)
-46.4%
current return
Author Info
No bio for this author
Company Info
Devyser Diagnostics AB (publ) provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.
Market Cap
SEK 1.1B
Pitch Price
SEK 114.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
18.35
P/E
70.41
EV/Sales
4.01
Sector
Biotechnology
Category
growth
The portfolio I am taking into 2026 - Devyser Diagnostics AB
DVYSR.ST: Swedish NGS diagnostics co targeting hereditary diseases, oncology, transplant medicine. FDA-approved IVD test kit could revolutionize US transplant monitoring, turning hospitals from cost to profit centers, potentially 20x revenue growth. 2026: 45x PE, 5.4x EV/Sales; 2027: 24x PE, 4.2x EV/Sales.
Read full article (1 min)